Literature DB >> 17685881

Treatment of fibromyalgia and its symptoms.

Roland Staud1.   

Abstract

The main symptoms of fibromyalgia syndrome (FM) are pain, stiffness, subjective weakness and muscle fatigue. Pain in FM usually fluctuates, as well as being 'deep' and is always associated with local or generalized tenderness (hyperalgesia and allodynia). The pathogenesis of such peripheral and/or CNS changes in FM is unclear, but peripheral tissue changes, specifically in muscles, have been implicated. Indirect evidence from interventions that attenuate tonic peripheral impulse input in patients with FM suggest that overall FM pain is dependent on nociception. More importantly, FM-associated widespread mechanical hyperalgesia and allodynia can also be improved or abolished by removal of peripheral pain impulse input. In addition, FM patients show evidence of abnormal stress reactivity, including blunting of the hypothalamic-pituitary-adrenal axis and increased autonomic nervous system responsiveness. Thus, therapeutic interventions in FM should target not only pain reductions, but also improvements of peripheral/central sensitization and neuroendocrine/autonomic abnormalities. Despite the complexity of FM, there are pharmacologic and non-pharmacologic interventions that are available that have clinical benefit. Present evidence indicates efficacy of antidepressants, cardiovascular exercise and cognitive behavioral therapy. Based on this evidence, a stepwise program emphasizing education, medications, exercise and cognitive therapy can be recommended.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17685881     DOI: 10.1517/14656566.8.11.1629

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  14 in total

1.  CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Authors:  John N Aucott; Mark J Soloski; Alison W Rebman; Lauren A Crowder; Lauren J Lahey; Catriona A Wagner; William H Robinson; Kathleen T Bechtold
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

Review 2.  Pregabalin: a review of its use in fibromyalgia.

Authors:  Katherine A Lyseng-Williamson; M Asif A Siddiqui
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Understanding fibromyalgia and its related disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Anatomical and physiological factors contributing to chronic muscle pain.

Authors:  Nicholas S Gregory; Kathleen A Sluka
Journal:  Curr Top Behav Neurosci       Date:  2014

5.  Fibromyalgia syndrome: an overview of pathophysiology, diagnosis and management.

Authors:  Firdous Jahan; Kashmira Nanji; Waris Qidwai; Rizwan Qasim
Journal:  Oman Med J       Date:  2012-05

6.  Fibromyalgia: From treatment to rehabilitation.

Authors:  Marta Imamura; David A Cassius; Felipe Fregni
Journal:  Eur J Pain       Date:  2009-11-01       Impact factor: 3.931

7.  ASIC3 Is Required for Development of Fatigue-Induced Hyperalgesia.

Authors:  Nicholas S Gregory; Renan G Brito; Maria Cláudia G Oliveira Fusaro; Kathleen A Sluka
Journal:  Mol Neurobiol       Date:  2015-01-11       Impact factor: 5.590

8.  Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.

Authors:  Enrico Bellato; Eleonora Marini; Filippo Castoldi; Nicola Barbasetti; Lorenzo Mattei; Davide Edoardo Bonasia; Davide Blonna
Journal:  Pain Res Treat       Date:  2012-11-04

Review 9.  Challenges of functional imaging research of pain in children.

Authors:  Simona Sava; Alyssa A Lebel; David S Leslie; Athena Drosos; Charles Berde; Lino Becerra; David Borsook
Journal:  Mol Pain       Date:  2009-06-16       Impact factor: 3.395

Review 10.  Chronic fatigue syndrome: aetiology, diagnosis and treatment.

Authors:  Alfredo Avellaneda Fernández; Alvaro Pérez Martín; Maravillas Izquierdo Martínez; Mar Arruti Bustillo; Francisco Javier Barbado Hernández; Javier de la Cruz Labrado; Rafael Díaz-Delgado Peñas; Eduardo Gutiérrez Rivas; Cecilia Palacín Delgado; Javier Rivera Redondo; José Ramón Ramón Giménez
Journal:  BMC Psychiatry       Date:  2009-10-23       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.